A Company Betting Its Physics-Based AI Will Fuel a Quantum Leap in Drug Discovery
The Bio Report - En podcast af Levine Media Group - Onsdage
Kategorier:
Tom Miller, co-founder and CEO of Iambic Therapeutics, discusses the company’s AI platform, the insights Iambic gains from using a quantum mechanics-based approach to drug discovery, and its growing pipeline of cancer therapies.
